Facilities that emit warfarin sodium, biocide manufactured by Nalco Chemicals and / or corrosion or scale inhibitor manufactured by Nalco Chemicals into the ambient air are required to ensure that their emissions of these substances do not result in the exceedance of the set concentration thresholds set for such substances for the air of residential and recreational areas.
The guidance is recommended for all organisations that emit radioactive substances into the ambient air from stationary air emission sources.
The guidance contains methods for monitoring air emissions of radioactive substances. Organisations may use monitoring methods other than those set out by the guidance, provided that the use of such methods has been justified.
As of 28 August 2017, revised greenhouse gas emission factors apply to facilities performing certain types of activity, including energy generation, production of cement, ammonia, phosphorus, etc. Greenhouse-gas (GHG) emission factors are set in the CO2 equivalent and are to be used to estimate emissions arising from producing a certain product unit.
As of 27 July 2017, individual air emission limits set for facilities and their emission sources (so-called “PDV projects”), are to be valid for 7 years, instead of 5.
Any facility emitting polluting substances into the ambient air is required to develop individual air emission limits (PDV Project) and to have it approved with the environmental authorities.
As of 1 January 2018, organisations that emit regulated hazardous substances into the ambient air, have to use the adopted methods for calculating the dispersion of air pollutant concentrations at the height of two meters from the ground level and at the distance not exceeding 100 km from the emission source as well as for vertical distribution of air pollutant concentrations.
The following methodologies have been adopted: